From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism

Abstract excerpt

Metabolic syndrome (MS) is a prevalent and severe comorbidity observed in schizophrenia (SZ). The exact nature of this association is controversial and very often accredited to the effects of psychotropic medications and disease-induced life-style modifications, such as inactive lifestyle, poor dietary choices, and smoking. However, drug therapy and disease-induced lifestyle factors are likely not the only...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lipid Membrane Structure and Behavior
• Share to Lysosomal Storage Disorders Research
• Share to Sphingolipid Metabolism and Signaling